Analysts Cut Cerence's Fair Value to $10, Citing Revenue Growth and Execution Concerns

Cerence's fair value estimate has been lowered from $12.50 to $10.00, a 20% cut, due to concerns about revenue growth and execution. Analysts, including Goldman Sachs and TD Cowen, have trimmed their price targets, signaling a more guarded tone around growth expectations and operational improvements. Recent news highlights Cerence's partnership expansion with Vivoka and its collaboration with Neusoft Corporation on large language model-based voice AI.